Talon Private Wealth »

Halozyme Therapeutics shares owned by Talon Private Wealth

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Talon Private Wealth from 13F filings

Historical chart of Talon Private Wealth investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Talon Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Talon Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $839k 11k 78.27

More positions owned by Talon Private Wealth

Bny Mellon Etf Trust Core Bond Etf (BKAG)
Etf Ser Solutions Aptus Defined (DRSK)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Innovator Etfs Trust Us Eqt Ultra Bf (UJAN)
Innovator Etfs Trust Us Eqt Ultra Bfr (UFEB)
Innovator Etfs Trust Us Eqt Ultra Bf (UMAR)
Innovator Etfs Trust Us Eqt Ultra Bf (UMAY)
Innovator Etfs Trust Us Eqt Ultra Bf (UJUN)
Ishares Tr Mbs Etf (MBB)
Micron Technology (MU)
Innovator Etfs Trust Inde Aut Inc Etf (ACII)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Etf Ser Solutions Aptus Enhanced (JUCY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Talon Private Wealth

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
Invesco
Robeco Investment Management
Bank of America Corporation
Geode Capital Management
William Blair Investment Management
Snyder Capital Management
Congress Asset Management
Dimensional Fund Advisors
D. E. Shaw & Co
Thomas Stevens, CFA"
Royal London Asset Management
Arrowstreet Capital, Limited Partnership

View all funds holding Halozyme Therapeutics